View Clinical Trial (Medical Research Study)


Behavioral Activation for Posttraumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans - NCT00805532-98108(Clinical Trial 362765)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Seattle
State:  
WA
Zip Code: 98108
Conditions: Posttraumatic Stress Disorder - Depression
Purpose: The present study is a randomized, controlled trial that compares Behavioral Activation (BA), to Usual VA Care (UC) as early psychotherapeutic interventions for OIF/OEF veterans with posttraumatic stress disorder (PTSD), or PTSD and major depressive disorder (PTSD/MDD).
Study summary: A sizable proportion of soldiers involved in the Iraq and Afghanistan conflicts are experiencing mental health and adjustment problems on their return, including posttraumatic stress disorder and depression (Hoge et al., 2004). Both PTSD and depression can be chronic and debilitating disorders, associated with impairments in social, occupational, and physical functioning, as well as high health care utilization (Katon, Unutzer, & Simon, 2004; Stein et al., 2005). Although empirically supported treatments exist for established PTSD and depression, much less is known about effective early interventions for these conditions. Exploration of early intervention options is necessary, particularly in the case of the new veteran population, as such interventions could address social, occupational and physical impairments before they become too intractable. Also, successful early interventions could curtail high health care utilization dramatically across time. The development of such early interventions for PTSD and depression must also take into account any specifications of accessibility and acceptability that are particular to the OIF/OEF veteran population. The present study is a randomized, controlled trial that compares Behavioral Activation (BA), to Usual VA Care (UC) as early interventions for OIF/OEF veterans with posttraumatic stress disorder (PTSD), or PTSD and major depressive disorder (PTSD/MDD). BA will be delivered in the primary health care setting (to increase acceptability and accessibility to the veteran population). Both BA and UC treatment groups will be administered by psychotherapists who specialize in the treatment of PTSD. Both groups will be assessed at pre-, mid- and several post-treatment time points to determine maintenance of diagnostic change over time, health care utilization and treatment satisfaction. This is a dual-site study that will be carried out at both the Portland VA Medical Center (PVAMC) and the VA Puget Sound Health Care Center (VA PSHCS) and coordinated at the PVAMC.
Criteria: Inclusion Criteria: 1. Ability to comply with assessment and therapy schedule. 2. Ability to comply with study regulations. 3. English fluency. 4. Must meet diagnostic criteria for PTSD (related to trauma experienced during military service) or PTSD (related to trauma experienced during the military) and major depressive disorder (MDD). PTSD will be assessed using the Clinician-Administered PTSD Scale for DSM-IV (CAPS; Blake, Weathers, Nagy, Kaloupek, Charney & Keane, 2003). Major Depressive Disorder (MDD) will be assessed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First, Spitzer, Gibbon & Williams, 2002). Exclusion Criteria: 1. Bipolar disorder. 2. Psychotic disorders. 3. Substance dependence. Because these conditions warrant alternative treatments. Bipolar, psychotic and substance dependence disorders will be assessed using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First, Spitzer, Gibbon & Williams, 2002). 4. Report active and imminent suicidal intent. If imminent suicidality is present, this would suggest that a treatment specifically targeting this intent is indicated. Suicidal intent will be assessed using The Brief Assessment for Suicidal Ideation or Behavior that was designed for this study.
Study is available at: VA Puget Sound Health Care System, Seattle
Seattle, WA 98108
United States

Primary Contact:
Matthew Jakupcak, PhD
Email: matthew.jakupcak@va.gov
Phone: 206-277-1853

Secondary Contact:
Margaret (Meg) T Kincaid
Email: margaret.kincaid@va.gov
Phone: (503) 220-8262
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.